(Q38345759)

2 September 2017

2 references

3 February 2021

Middle East respiratory syndrome: An emerging coronavirus infection tracked by the crowd (English)

1 reference

25656066

Middle East respiratory syndrome coronavirus

2 September 2017

main subject

0 references

0 references

1 reference

3 February 2021

1 reference

Middle East respiratory syndrome

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25656066%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Katherine E. Arden

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25656066%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

2 February 2015

1 reference

25656066

2 September 2017

16 April 2015

1 reference

3 February 2021

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25656066%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

3 February 2021

202

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25656066%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

60-88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25656066%20AND%20SRC:MED&resulttype=core&format=json

Middle East respiratory syndrome coronavirus (MERS-CoV): evidence and speculations.

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Investigation of anti-middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Middle East respiratory syndrome coronavirus: transmission and phylogenetic evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Camel urine components display anti-cancer properties in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Middle East Respiratory Syndrome Coronavirus Infection in Dromedary Camels in Saudi Arabia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Middle East respiratory syndrome coronavirus antibody reactors among camels in Dubai, United Arab Emirates, in 2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

The antiplatelet activity of camel urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Hospital outbreak of Middle East respiratory syndrome coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Evidence for camel-to-human transmission of MERS coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Detection of the Middle East respiratory syndrome coronavirus genome in an air sample originating from a camel barn owned by an infected patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Viral respiratory infections among Hajj pilgrims in 2013.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Assessing the pandemic potential of MERS-CoV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

The multifunctional or moonlighting protein CD26/DPPIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Call for infection control to stem MERS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

The Effects of Temperature and Relative Humidity on the Viability of the SARS Coronavirus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Crystal Structure of the Receptor-Binding Domain from Newly Emerged Middle East Respiratory Syndrome Coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Synthesizing data and models for the spread of MERS-CoV, 2013: key role of index cases and hospital transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Acute renal impairment in coronavirus-associated severe acute respiratory syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Rooting the phylogenetic tree of middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Laboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Malaysia: preparedness and response, April 2014.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

7 January 2021

Is MERS another SARS?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Transmission of MERS-coronavirus in household contacts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

An observational, laboratory-based study of outbreaks of middle East respiratory syndrome coronavirus in Jeddah and Riyadh, kingdom of Saudi Arabia, 2014.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Age-specific and sex-specific morbidity and mortality from avian influenza A(H7N9).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Replicative Capacity of MERS Coronavirus in Livestock Cell Lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) Coronavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

MERS-CoV: address the knowledge gaps to move forward

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Lack of nasal carriage of novel corona virus (HCoV-EMC) in French Hajj pilgrims returning from the Hajj 2012, despite a high rate of respiratory symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Lack of MERS coronavirus neutralizing antibodies in humans, eastern province, Saudi Arabia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Human-Dromedary Camel Interactions and the Risk of Acquiring Zoonotic Middle East Respiratory Syndrome Coronavirus Infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Loss of dipeptidylpeptidase IV activity in chronic rhinosinusitis contributes to the neurogenic inflammation induced by substance P in the nasal mucosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013.

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

7 January 2021

inferred from DOI database lookup

Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

MERS-CoV enigma deepens as reported cases surge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

The safety of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter 2 (SGLT-2) inhibitors added to metformin background therapy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Ribavirin and interferon-α2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Structural and functional characterization of MERS coronavirus papain-like protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Increased Expression of Plasma and CD4+ T Lymphocyte Costimulatory Molecule CD26 in Adult Patients with Allergic Asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Co-circulation of four human coronaviruses (HCoVs) in Queensland children with acute respiratory tract illnesses in 2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Middle East respiratory syndrome coronavirus: implications for health care facilities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Middle East respiratory syndrome coronavirus disease in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Prevalence of MERS-CoV nasal carriage and compliance with the Saudi health recommendations among pilgrims attending the 2013 Hajj

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Middle East respiratory syndrome coronavirus (MERS-CoV) viral shedding in the respiratory tract: an observational analysis with infection control implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Community case clusters of Middle East respiratory syndrome coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: a descriptive genomic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Middle East respiratory syndrome coronavirus in bats, Saudi Arabia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Family cluster of Middle East respiratory syndrome coronavirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Serological assays for emerging coronaviruses: challenges and pitfalls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Serologic assessment of possibility for MERS-CoV infection in equids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Camel milk as an adjuvant therapy for the treatment of type 1 diabetes: verification of a traditional ethnomedical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Pneumonia from human coronavirus in a macaque model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Missing information in animal surveillance of MERS-CoV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Stillbirth during infection with Middle East respiratory syndrome coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

MERS: emergence of a novel human coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Specific serology for emerging human coronaviruses by protein microarray

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

7 January 2021

12 December 2020

Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Contact investigation for imported case of Middle East respiratory syndrome, Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

IL-10 family of cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Influenza A (H7N9) and the importance of digital epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Middle East respiratory syndrome: what clinicians need to know

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

A highly conserved WDYPKCDRA epitope in the RNA directed RNA polymerase of human coronaviruses can be used as epitope-based universal vaccine design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Emerging infectious diseases associated with bat viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Bats and their virome: an important source of emerging viruses capable of infecting humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Reliable typing of MERS-CoV variants with a small genome fragment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Coronavirus diversity, phylogeny and interspecies jumping

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Rapid generation of a mouse model for Middle East respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Infection control and MERS-CoV in health-care workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

Middle East respiratory syndrome coronavirus: epidemic potential or a storm in a teacup?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.01.021

MERS coronavirus in dromedary camel herd, Saudi Arabia

7 January 2021

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus (MERS-CoV) RNA and neutralising antibodies in milk collected according to local customs from dromedary camels, Qatar, April 2014.

1 reference

12 December 2020

Recovery from severe novel coronavirus infection.

1 reference

12 December 2020

Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus

1 reference

12 December 2020

Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992-2013

1 reference

12 December 2020

MERS coronaviruses in dromedary camels, Egypt.

1 reference

12 December 2020

Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity

1 reference

12 December 2020

Evidence for camel-to-human transmission of MERS coronavirus

1 reference

12 December 2020

Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013.

1 reference

12 December 2020

Investigation of an imported case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Florence, Italy, May to June 2013.

1 reference

12 December 2020

Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction

1 reference

12 December 2020

Full-genome sequence of human betacoronavirus 2c jordan-n3/2012 after serial passage in Mammalian cells

1 reference

12 December 2020

Geographic distribution of MERS coronavirus among dromedary camels, Africa

1 reference

12 December 2020

A case of imported Middle East Respiratory Syndrome coronavirus infection and public health response, Greece, April 2014.

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels, Oman, 2013.

1 reference

12 December 2020

Novel coronavirus: the challenge of communicating about a virus which one knows little about

1 reference

12 December 2020

Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation

1 reference

12 December 2020

Lack of middle East respiratory syndrome coronavirus transmission from infected camels

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia

1 reference

12 December 2020

Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans

1 reference

12 December 2020

First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities -

1 reference

12 December 2020

Taking stock of the first 133 MERS coronavirus cases globally--Is the epidemic changing?

1 reference

12 December 2020

Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines

1 reference

12 December 2020

Beneficial effect of camel milk in diabetic nephropathy.

1 reference

12 December 2020

Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012.

1 reference

12 December 2020

Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions.

1 reference

12 December 2020

A case of long-term excretion and subclinical infection with Middle East respiratory syndrome coronavirus in a healthcare worker.

1 reference

12 December 2020

The camel connection.

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus not detected in children hospitalized with acute respiratory illness in Amman, Jordan, March 2010 to September 2012

1 reference

12 December 2020

First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013.

1 reference

12 December 2020

State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans

1 reference

12 December 2020

Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections.

1 reference

12 December 2020

Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013.

1 reference

12 December 2020

Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013.

1 reference

12 December 2020

Accuracy of epidemiological inferences based on publicly available information: retrospective comparative analysis of line lists of human cases infected with influenza A(H7N9) in China

1 reference

12 December 2020

Spousal diabetes as a diabetes risk factor: a systematic review and meta-analysis

1 reference

12 December 2020

Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014

1 reference

12 December 2020

10.1016/J.VIRUSRES.2015.01.021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25656066%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25656066%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

25656066

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25656066%20AND%20SRC:MED&resulttype=core&format=json